Manganese carbonate nanoparticles‐mediated mitochondrial dysfunction for enhanced sonodynamic therapy
Citations Over TimeTop 10% of 2021 papers
Abstract
Sonodynamic therapy (SDT) has attracted widespread attention due to its non-invasiveness and deep tissue penetration. However, the development of efficient sonodynamic nanoplatforms to improve the therapeutic efficiency is still one of the main challenges of current research. In this work, a new type of sonosensitizer prepared by a simple method, manganese carbonate nanoparticles (MnCO3 NPs), is used for enhanced SDT. MnCO3 NPs could generate large amounts of 1O2 and •OH under ultrasound irradiation. At the same time, CO2 and Mn ions could be released in a weak acid environment due to the excellent degradability of MnCO3 NPs. The CO2 bubbles caused cell necrosis by ultrasonic cavitation and used for ultrasound imaging. And Mn ions activated the mitochondrial cell apoptosis pathway. In vivo experiments proved that this sonosensitizer with mitochondrial regulatory capacity showed high tumor inhibition rates for enhanced sonodynamic tumor therapy.
Related Papers
- → Recent advances of sonodynamic therapy in cancer treatment(2016)293 cited
- → Nanoparticles in sonodynamic therapy: state of the art review(2016)101 cited
- → Development of porphyrin and titanium dioxide sonosensitizers for sonodynamic cancer therapy.(2021)9 cited
- → Nanostructured and molecular ROS generators for Photo- and Sonodynamic therapy(2022)
- → Focused ultrasound-augmented targeting delivery of nanosonosensitizers from homogenous exosomes for enhanced sonodynamic cancer therapy: Erratum(2022)